Clinical Trials on Spinal Muscular Atrophy Type 2
Total 0 results
Nothing found
Sponsors and Collaborators
- Singapore Polytechnic University
- Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group
- Loblaw Companies Ltd.
- Haining People' s Hospital
- Universitätsklinikum Ulm
- Sara C. Folta
- Prostate Cure Foundation
- Geauga Rehabilitation Engineering, Inc.
- Hydrocephalus Association
- MediGene
- Theravant Corporation
- BG Klinikum Frankfurt Main
- United Health Foundation
- Julia Upton, Hospital for Sick Children, University of Toronto
- Rizhao People's Hospital
- Cyclo Therapeutics, Inc.
- Tritech Biopharmaceuticals Co., Ltd.
- J. Peter Rubin, MD
- Dan Liu
- Kirsehir Ahi Evran Universitesi
- View Full List
Medical Conditions
- Painful Avulsion of Brachial Plexus
- Software Evaluation for Visualizing Anatomical Structures That Are Not Typically Identified on Clinical MR Images
- Naked Eye 3D Vision Training
- History of a Fall in the Previous 12 Months
- Liver Transplanted Patients
- Metastatic Renal Cell Carcinoma ( mRCC)
- Deficits, Neurologic
- Vancomycin Therapy
- Tricuspid Regurgitation
- Dystussia
- Unresectable Colon Adenocarcinoma
- Spinocerebellar Ataxia 1
- Determine the Number of Anatomical Sites at Which Successful Thermoacoustic Fat Measurements Can be Made From Five Acquisitions Using the FLIP ITA Device
- Retinal Ischemia
- Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)
- Mind Body Awareness
- Glioma Glioblastoma Multiforme
- Vitamin A Deficiency
- Patient Spe
- Organ Dysfunction
- View Full List
Drug Interventions
- Dialyzable Leukocyte Extract
- Trimethoprim/Sulfamethoxazole
- BLU-5937 ER
- Colchicine 0.5 MG
- Sildenafil
- Azacitidine Injection
- Polyhexamethylene biguanide (PHMB)
- Axitinib
- Tetracycline hydrochloride 3%
- Vitamin K supplement
- RTX-GRT7039
- URC102 0.25mg
- Novo Glucagon
- Pregabalin 75mg
- Pyrotinib
- Injection of ADRC's
- MAXCLARITY II (2.5% BPO) Foam Treatment
- ZL-1102 3% w/w gel QD for 16 weeks
- Lenvatinib
- PARP inhibitor
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Canada
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Mexico
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Morocco
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Oman
- Contract Research Organizations in Senegal
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Tanzania
- Contract Research Organizations in United States
- Contract Research Organizations in Vietnam
- CRO list by country